DGAP-News: RHÃN-KLINIKUM AG / Key word(s): Final Results
RHÃN-KLINIKUM AG: Accounts press conference in Frankfurt am Main on 25
April 2013
25.04.2013 / 07:00
---------------------------------------------------------------------
Annual results 2012
ï§ Renewed increase in patients treated of 12.2 % is evidence of confidence
in the quality of care and medical capability
ï§ 9.0 % revenue growth in a challenging regulatory environment
ï§ Growth driven by the integration of the HSK in Wiesbaden
ï§ 42.9 % decline in earnings, mainly due to setbacks in the UKGM
restructuring and other non-recurring charges
Results of Q1 2013
ï§ Increase of 60,781 or 10.0 % in number of patients to a total of 670,677
cases underlines a good start to the new financial year
ï§ Revenue grows by 10.2 % to EUR752.2 million
ï§ Consolidated net profit decreases by EUR9.8 million or 28.7 % to EUR24.3
million
ï§ EBIT falls by EUR8.6 million or 17.7 % to EUR39.9 million
ï§ EBITDA shrinks by EUR6.9 million or 8.4 % to EUR74.9 million
In 2012, nearly 2.6 million patients were treated in the Group's hospitals.
In the same period, revenue rose to EUR2.86 billion. Due to setbacks in the
restructuring of the University Hospital GieÃen and Marburg (UKGM),
non-recurring charges connected to the Fresenius takeover bid, increased
regulatory pressure and a negative contribution from Dr. Horst Schmidt
Kliniken Wiesbaden (HSK), which was consolidated for the first time in
2012, consolidated net profit fell 42.9 % to EUR92.0 million. EBITDA,
adjusted for the effect of the Siemens compensation payment with regard to
'PTZ Marburg' in the 2011 financial year, declined by 13.7 % to EUR291.5
million year-on-year, and EBIT fell 29.5 % to EUR150.3 million.
'Despite the eventful and difficult 2012 financial year, RHÃN-KLINIKUM AG's
revenue and patient numbers are rising steadily. The continuing
attractiveness of our services is clearly strengthened by this show of
confidence. Nonetheless, the cost situation overall is unsatisfactory,'
said Dr Martin Siebert, Chairman of the Board of Management at
RHÃN-KLINIKUM AG.
At this year's Annual General Meeting on 12 June 2013, the Board of
Management and Supervisory Board will propose a dividend distribution of
EUR0.25 (previous year: EUR0.45) per share entitled to dividend (DE
0007042301; 138,232,000 shares).
Jobs 2012
As of 31 December 2012, RHÃN-KLINIKUM AG employed 43,059 people in ten
German states. That is once again more than the year before. In many
regions, the hospitals of the RHÃN-KLINIKUM Group are among the largest
employers.
Results of Q1 2013
670,677 patients were treated in the first three months of the current
financial year (+10.0 %). Revenue grew to EUR752.2 million (+10.2 %).
Consolidated net profit fell by 28.7 % to EUR24.3 million. EBITDA decreased
to EUR74.9 million (-8.4 %). EBIT declined to EUR39.9 million and is thus
17.7 % lower than in the previous year.
Outlook for 2013
The company has confirmed its forecast for 2013 as a whole. In 2013,
RHÃN-KLINIKUM AG expects revenue of EUR3.03 billion, plus or minus 2.5 %.
This revenue target is accompanied by an EBITDA forecast of EUR325 million
and a consolidated net profit forecast of EUR110 million, each with a
fluctuation range of +/- 5 %.
'We are confident that the structural, procedural and staffing measures of
recent months have laid the first important foundations for making the
company more competitive, so that RHÃN-KLINIKUM AG can return to where we
believe it belongs: at the very top of the market. The institutional basis
for this will be provided by a systematic Group-wide optimisation
programme, currently being launched, which relates to our traditional
strengths and also enriches our tried-and-tested business model with fresh
stimulus,' said Dr Martin Siebert, Chairman of the Board of Management at
RHÃN-KLINIKUM AG.
'The goal is clear: step by step, we want to rebuild the company as an
integrated health group, in which knowledge, skills, technologies and
processes are first and foremost systematically shared and closely
interlinked to a much greater degree than before. In the future, a
strengthened University Hospital GieÃen and Marburg will play a more
important role as a 'medical technology hub' for all Group hospitals,' the
Board of Management Chairman said.
Wiesbaden's Dr. Horst Schmidt Kliniken (HSK) is being integrated into the
company 'energetically': 'We are on budget and expect to achieve the first
positive monthly results in the third quarter of this year. Achieving our
profitability targets is therefore not an end in itself, but rather the
necessary financial requirement not only to uphold our long-held credo of
affordable top-quality medical care for everyone, but also to improve on
it,' said Siebert.
End of Corporate News
---------------------------------------------------------------------
25.04.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: RHÃN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a.d.Saale
Germany
Phone: +49 (0)9771 - 65-0
Fax: +49 (0)9771 - 97 467
E-mail: rka@rhoen-klinikum-ag.com
Internet: www.rhoen-klinikum-ag.com
ISIN: DE0007042301
WKN: 704230
Indices: MDAX
Listed: Regulierter Markt in Frankfurt (Prime Standard), München;
Freiverkehr in Berlin, Düsseldorf, Hamburg, Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
208463 25.04.2013
DGAP-News: RHÃN-KLINIKUM AG: Accounts press conference in Frankfurt am Main on 25 April 2013
| Source: EQS Group AG